INMUNOENSAYO PARA LA DETERMINACIÓN DE LA PROTEÍNA β-AMILOIDE.
Mexico·Clase I·III. Agentes de diagnóstico·PRODUCTOS ROCHE,
S.A. DE C.V.·Registered December 16, 2022- Risk Class / Clase de Riesgo
- Clase I
- Product Type (Spanish)
- III. Agentes de diagnóstico
- Product Type (English)
- III. Agentes de diagnóstico
- Trade Name (Spanish)
- ELECSYS β-AMYLOID (1-42) CSF.
- Trade Name (English)
- ELECSYS β-AMYLOID (1-42) CSF.
- Analysis ID
- 1658R2022 SSA
- Registration Date
- December 16, 2022
- Name (Spanish)
- PRODUCTOS ROCHE, S.A. DE C.V.
- Name (English)
- PRODUCTOS ROCHE, S.A. DE C.V.
Access comprehensive regulatory information for INMUNOENSAYO PARA LA DETERMINACIÓN DE LA PROTEÍNA β-AMILOIDE. (INMUNOENSAYO PARA LA DETERMINACIÓN DE LA PROTEÍNA β-AMILOIDE.) in the Mexico medical device market through Pure Global AI's free database. This Clase I medical device is registered under COFEPRIS analysis ID 1658R2022 SSA and manufactured by PRODUCTOS ROCHE, S.A. DE C.V.. The device was registered on December 16, 2022.
This page provides complete registration details including product type (III. Agentes de diagnóstico), manufacturer information, and regulatory compliance data from the official Mexico COFEPRIS medical device database. Pure Global AI offers free access to Mexico's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate COFEPRIS regulations efficiently.